-
1
-
-
0028068659
-
Symptom prevalence, characteristics, and distress in a cancer population
-
1. Portenoy RK, Thaler HT, Kornblith AB, et al. Symptom prevalence, characteristics, and distress in a cancer population. Qual Life Res 1994; 3: 183-9.
-
(1994)
Qual Life Res
, vol.3
, pp. 183-189
-
-
Portenoy, R.K.1
Thaler, H.T.2
Kornblith, A.B.3
-
2
-
-
0030061015
-
Symptom assessment
-
Cherny N, Foley K, eds. Philadelphia: WB Saunders Company
-
2. Ingham JM, Portenoy RK. Symptom assessment. In: Cherny N, Foley K, eds. Pain and palliative care: hematology/oncology clinics of North America. Philadelphia: WB Saunders Company, 1996; 10: 21-39.
-
(1996)
Pain and Palliative Care: Hematology/Oncology Clinics of North America
, vol.10
, pp. 21-39
-
-
Ingham, J.M.1
Portenoy, R.K.2
-
3
-
-
0025910622
-
Correlation of patient and caregiver ratings of cancer pain
-
3. Grossman SA, Sheidler VR, Sweden K, et al. Correlation of patient and caregiver ratings of cancer pain. J Pain Symp Manage 1991; 6: 53-7.
-
(1991)
J Pain Symp Manage
, vol.6
, pp. 53-57
-
-
Grossman, S.A.1
Sheidler, V.R.2
Sweden, K.3
-
4
-
-
0020565258
-
The validation of visual analogue scales as a ratio scale measurement for chronic and experimental pain
-
4. Price DD, MacGrath PA, Rafii A, Buckingham B. The validation of visual analogue scales as a ratio scale measurement for chronic and experimental pain. Pain 1983; 17: 45-56.
-
(1983)
Pain
, vol.17
, pp. 45-56
-
-
Price, D.D.1
MacGrath, P.A.2
Rafii, A.3
Buckingham, B.4
-
5
-
-
0002197461
-
Audit methods: The Edmonton symptom assessment system
-
Higginson I, ed. Oxford: Radcliffe Medical Press
-
5. Bruera E, MacDonald S. Audit methods: the Edmonton Symptom Assessment System. In: Higginson I, ed. Clinical audit in palliative care. Oxford: Radcliffe Medical Press, 1993: 61-77.
-
(1993)
Clinical Audit in Palliative Care
, pp. 61-77
-
-
Bruera, E.1
MacDonald, S.2
-
6
-
-
0002354145
-
Audit methods: Validation and in-patient use
-
Higginson I, ed. Oxford: Radcliffe Medical Press
-
6. Higginson I. Audit methods: validation and in-patient use. In: Higginson I, ed. Clinical audit in palliative care. Oxford: Radcliffe Medical Press, 1993: 48-54.
-
(1993)
Clinical Audit in Palliative Care
, pp. 48-54
-
-
Higginson, I.1
-
7
-
-
0023271255
-
The memorial pain assessment card. A valid instrument for the evaluation of cancer pain
-
7. Fishman B, Pasternak S, Wallenstein SL, et al. The Memorial Pain Assessment Card. A valid instrument for the evaluation of cancer pain. Cancer 1987; 60: 1151-8.
-
(1987)
Cancer
, vol.60
, pp. 1151-1158
-
-
Fishman, B.1
Pasternak, S.2
Wallenstein, S.L.3
-
8
-
-
0028033880
-
The memorial symptom assessment scale. An instrument for the evaluation of symptom prevalence, characteristics and distress
-
8. Portenoy RK, Thaler HT, Kornblith AB, et al. The Memorial Symptom Assessment Scale. An instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer 1994; 30A: 1326-36.
-
(1994)
Eur J Cancer
, vol.30 A
, pp. 1326-1336
-
-
Portenoy, R.K.1
Thaler, H.T.2
Kornblith, A.B.3
-
9
-
-
0018887475
-
Use of the McGill pain questionnaire in the assessment of cancer pain: Replicability and consistency
-
9. Graham C, Bond SS, Genkovich MM, et al. Use of the McGill Pain Questionnaire in the assessment of cancer pain: replicability and consistency. Pain 1980; 8: 377-87.
-
(1980)
Pain
, vol.8
, pp. 377-387
-
-
Graham, C.1
Bond, S.S.2
Genkovich, M.M.3
-
10
-
-
0020603115
-
Development of the Wisconsin brief pain questionnaire to assess pain in cancer and other diseases
-
10. Dant RL, Cleeland CS, Flarery RC. Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases. Pain 1983; 17: 147-210.
-
(1983)
Pain
, vol.17
, pp. 147-210
-
-
Dant, R.L.1
Cleeland, C.S.2
Flarery, R.C.3
-
11
-
-
0025639135
-
Measuring psychological and physical distress in cancer patients: Structure and application of the Rotterdam symptom checklist
-
11. de Haes JCJM, van Kipperberg FCE, Neijt JP. Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist. Br J Cancer 1990; 62: 1034.
-
(1990)
Br J Cancer
, vol.62
, pp. 1034
-
-
De Haes, J.C.J.M.1
Van Kipperberg, F.C.E.2
Neijt, J.P.3
-
12
-
-
0018023522
-
Development of a symptom distress scale
-
12. McCorkle R, Young K. Development of a symptom distress scale. Cancer Nurs 1978; 1: 373-8.
-
(1978)
Cancer Nurs
, vol.1
, pp. 373-378
-
-
McCorkle, R.1
Young, K.2
-
13
-
-
0027943192
-
Regular use of a verbal pain scale improves the understanding of oncology inpatient intensity
-
13. Au E, Loprinzi CL, Dhodapkar M, et al. Regular use of a verbal pain scale improves the understanding of oncology inpatient intensity. J Clin Oncol 1994; 12: 2751-5.
-
(1994)
J Clin Oncol
, vol.12
, pp. 2751-2755
-
-
Au, E.1
Loprinzi, C.L.2
Dhodapkar, M.3
-
14
-
-
0025281813
-
Palliative care in a cancer centre: Results in 1984 versus 1987
-
14. Bruera E, Macmillan K, Hanson J, et al. Palliative care in a cancer centre: results in 1984 versus 1987. J Pain Symp Manage 1990; 5: 1-5.
-
(1990)
J Pain Symp Manage
, vol.5
, pp. 1-5
-
-
Bruera, E.1
Macmillan, K.2
Hanson, J.3
-
15
-
-
0029021038
-
A prospective multi-center assessment of the Edmonton staging system for cancer pain
-
15. Bruera E, Schoeller T, Wenk R, et al. A prospective multi-center assessment of the Edmonton Staging System for cancer pain. J Pain Symp Manage 1995; 10: 348-55.
-
(1995)
J Pain Symp Manage
, vol.10
, pp. 348-355
-
-
Bruera, E.1
Schoeller, T.2
Wenk, R.3
-
16
-
-
0028857831
-
Case report: Is this opioid analgesic tolerance?
-
16. Fainsinger R, Bruera E. Case report: is this opioid analgesic tolerance? J Pain Symp Manage 1995; 10: 573-7.
-
(1995)
J Pain Symp Manage
, vol.10
, pp. 573-577
-
-
Fainsinger, R.1
Bruera, E.2
-
17
-
-
0024354949
-
The Edmonton staging system for cancer pain: Preliminary report
-
17. Bruera E, Macmillan K, Hanson J, MacDonald RN. The Edmonton staging system for cancer pain: preliminary report. Pain 1989; 37: 203-9.
-
(1989)
Pain
, vol.37
, pp. 203-209
-
-
Bruera, E.1
Macmillan, K.2
Hanson, J.3
MacDonald, R.N.4
-
18
-
-
0031038731
-
The frequency and clinical course of cognitive impairment in patients with terminal cancer
-
18. Pereira J, Hanson J, Bruera E. The frequency and clinical course of cognitive impairment in patients with terminal cancer. Cancer 1997; 79: 835-42.
-
(1997)
Cancer
, vol.79
, pp. 835-842
-
-
Pereira, J.1
Hanson, J.2
Bruera, E.3
-
19
-
-
0026624722
-
Cognitive failure in patients with terminal cancer: A prospective study
-
19. Bruera E, Miller L, McCallion J, Macmillan K, Krefting L, Hanson J. Cognitive failure in patients with terminal cancer: a prospective study. J Pain Symp Manage 1992; 7: 192-5.
-
(1992)
J Pain Symp Manage
, vol.7
, pp. 192-195
-
-
Bruera, E.1
Miller, L.2
McCallion, J.3
Macmillan, K.4
Krefting, L.5
Hanson, J.6
-
20
-
-
0028914128
-
A critique of instruments and methods to detect, diagnose, and rate delirium
-
20. Smith MJ, Breitbart WS, Platt MM. A critique of instruments and methods to detect, diagnose, and rate delirium. J Pain Symp Manage 1995; 10: 37-77.
-
(1995)
J Pain Symp Manage
, vol.10
, pp. 37-77
-
-
Smith, M.J.1
Breitbart, W.S.2
Platt, M.M.3
-
21
-
-
0020627785
-
Validation of a short orientation-memory-concentration test of cognitive impairment
-
21. Katzman R, Brown T, Field P, et al. Validation of a short orientation-memory-concentration test of cognitive impairment. Am J Psychiatry 1983; 140: 734-9.
-
(1983)
Am J Psychiatry
, vol.140
, pp. 734-739
-
-
Katzman, R.1
Brown, T.2
Field, P.3
-
22
-
-
0030955090
-
The memorial delirium assessment scale
-
22. Breitbart W, Rosenfeld B, Roth A, Smith MJ, Cohen K, Passik S. The Memorial Delirium Assessment Scale. J Pain Symp Manage 1997; 13: 128-37.
-
(1997)
J Pain Symp Manage
, vol.13
, pp. 128-137
-
-
Breitbart, W.1
Rosenfeld, B.2
Roth, A.3
Smith, M.J.4
Cohen, K.5
Passik, S.6
-
23
-
-
0024600152
-
Prevalence, detection and treatment of alcoholism in hospitalized patients
-
23. Moore RD, Bone LR, Geller G, et al. Prevalence, detection and treatment of alcoholism in hospitalized patients. J Am Med Assoc 1989; 261: 403-7.
-
(1989)
J Am Med Assoc
, vol.261
, pp. 403-407
-
-
Moore, R.D.1
Bone, L.R.2
Geller, G.3
-
24
-
-
0028803552
-
The frequency of alcoholism among patients with pain due to terminal cancer
-
24. Bruera E, Moyano J, Seifert L, Fainsinger RL, Hanson J, Suarez-Almazor M. The frequency of alcoholism among patients with pain due to terminal cancer. J Pain Symp Manage 1995; 10: 599-603.
-
(1995)
J Pain Symp Manage
, vol.10
, pp. 599-603
-
-
Bruera, E.1
Moyano, J.2
Seifert, L.3
Fainsinger, R.L.4
Hanson, J.5
Suarez-Almazor, M.6
-
25
-
-
0021141362
-
The Karnofsky performance status scale; an examination of its reliability and validity in a research setting
-
25. Mor V, Laliberte L, Morris JN, Wiemann M. The Karnofsky Performance Status Scale; an examination of its reliability and validity in a research setting. Cancer 1984; 53: 2002-7.
-
(1984)
Cancer
, vol.53
, pp. 2002-2007
-
-
Mor, V.1
Laliberte, L.2
Morris, J.N.3
Wiemann, M.4
-
26
-
-
0027417437
-
A quality-of-life instrument for use in international clinical trials in oncology
-
26. Aaronson NK, Ahmedzai S, Bergman B, et al. European Organization for Research and Treatment of Cancer Study Group on Quality of Life. The European Organization for Research and Treatment of Cancer Study Group on Quality of Life-30. A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85: 365-76.
-
(1993)
J Natl Cancer Inst
, vol.85
, pp. 365-376
-
-
Aaronson, N.K.1
Ahmedzai, S.2
Bergman, B.3
-
27
-
-
0031020055
-
The Edmonton functional assessment tool: Preliminary development and evaluation for use in palliative care
-
27. Kaasa T, Loomis J, Gillis K, et al. The Edmonton Functional Assessment Tool: preliminary development and evaluation for use in palliative care. J Pain Symp Manage 1997; 13: 10-9.
-
(1997)
J Pain Symp Manage
, vol.13
, pp. 10-19
-
-
Kaasa, T.1
Loomis, J.2
Gillis, K.3
-
28
-
-
0028558528
-
The assessment of constipation in terminal cancer patients admitted to a palliative care unit: A retrospective review
-
28. Bruera E, Suarez-Almazor M, Velasco A, Bertolino M, MacDonald SM, Hanson J. The assessment of constipation in terminal cancer patients admitted to a palliative care unit: a retrospective review. J Pain Symp Manage 1994; 9: 515-9.
-
(1994)
J Pain Symp Manage
, vol.9
, pp. 515-519
-
-
Bruera, E.1
Suarez-Almazor, M.2
Velasco, A.3
Bertolino, M.4
MacDonald, S.M.5
Hanson, J.6
-
30
-
-
0027407786
-
The functional assessment of cancer therapy scale: Development and validation of the general measure
-
30. Cella DF, Tulsky DJ, Gray G, et al. The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 1993; 11: 570-9.
-
(1993)
J Clin Oncol
, vol.11
, pp. 570-579
-
-
Cella, D.F.1
Tulsky, D.J.2
Gray, G.3
-
31
-
-
0019841594
-
Measuring the quality of life of cancer patients; a concise QL-index for use by physicians
-
31. Spitzer WU, Dobson AJ, Hall J, et al. Measuring the quality of life of cancer patients; a concise QL-index for use by physicians. J Chronic DTS 1981; 34: 585-97.
-
(1981)
J Chronic DTS
, vol.34
, pp. 585-597
-
-
Spitzer, W.U.1
Dobson, A.J.2
Hall, J.3
-
32
-
-
0031051008
-
Validity of the McGill quality of life questionnaire in the palliative care setting: A multi-centre Canadian study demonstrating the importance of the existential domain
-
32. Cohen SR, Mount BM, Bruera E, Provost M, Rowe J, Ton K. Validity of the McGill Quality of Life Questionnaire in the palliative care setting: a multi-centre Canadian study demonstrating the importance of the existential domain. Palliat Med 1997; 11: 3-20.
-
(1997)
Palliat Med
, vol.11
, pp. 3-20
-
-
Cohen, S.R.1
Mount, B.M.2
Bruera, E.3
Provost, M.4
Rowe, J.5
Ton, K.6
-
33
-
-
0021839202
-
The treatment of cancer pain
-
33. Foley K. The treatment of cancer pain. N Engl J Med 1985; 313: 84-95.
-
(1985)
N Engl J Med
, vol.313
, pp. 84-95
-
-
Foley, K.1
-
34
-
-
0024324299
-
Cancer pain epidemiology and symptoms
-
34. Portenoy RK. Cancer pain epidemiology and symptoms. Cancer 1989; 63: 2298-307.
-
(1989)
Cancer
, vol.63
, pp. 2298-2307
-
-
Portenoy, R.K.1
-
35
-
-
0003527864
-
-
Geneva: World Health Organization
-
35. World Health Organization. Cancer pain relief. 2nd ed. Geneva: World Health Organization, 1996.
-
(1996)
Cancer Pain Relief. 2nd Ed.
-
-
-
36
-
-
0027461203
-
Opiophobia and cancer pain in Europe
-
36. Zenz M, Willweber-Strumpf A. Opiophobia and cancer pain in Europe. Lancet 1993; 341: 1075-6.
-
(1993)
Lancet
, vol.341
, pp. 1075-1076
-
-
Zenz, M.1
Willweber-Strumpf, A.2
-
38
-
-
0003377893
-
From Florianopolis 1994 to Santo Domingo 1996: A progress report on opioid availability
-
38. de Lima L, Bruera E, Joranson DE, et al. From Florianopolis 1994 to Santo Domingo 1996: a progress report on opioid availability. Cancer Pain Release 1996; 9: 4-5.
-
(1996)
Cancer Pain Release
, vol.9
, pp. 4-5
-
-
De Lima, L.1
Bruera, E.2
Joranson, D.E.3
-
39
-
-
0028969147
-
Neuropsychiatric syndromes and psychological symptoms in patients with advanced cancer
-
39. Breitbart W, Bruera E, Chochinov H, Lynch M. Neuropsychiatric syndromes and psychological symptoms in patients with advanced cancer. J Pain Symp Manage 1995; 10: 131-41.
-
(1995)
J Pain Symp Manage
, vol.10
, pp. 131-141
-
-
Breitbart, W.1
Bruera, E.2
Chochinov, H.3
Lynch, M.4
-
40
-
-
0031038731
-
The frequency and clinical course of cognitive impairment in patients with terminal cancer
-
40. Pereira J, Hanson J, Bruera E. The frequency and clinical course of cognitive impairment in patients with terminal cancer. Cancer 1997; 79: 835-42.
-
(1997)
Cancer
, vol.79
, pp. 835-842
-
-
Pereira, J.1
Hanson, J.2
Bruera, E.3
-
41
-
-
0030579008
-
Pharmacologic treatment of cancer pain
-
41. Levy MH. Pharmacologic treatment of cancer pain. New Engl J Med 1996; 335: 1124-32.
-
(1996)
New Engl J Med
, vol.335
, pp. 1124-1132
-
-
Levy, M.H.1
-
42
-
-
0028246011
-
Management of common opioid side effects during long term therapy of cancer pain
-
42. Portenoy RK. Management of common opioid side effects during long term therapy of cancer pain. Ann Acad Med 1994; 23: 160-70.
-
(1994)
Ann Acad Med
, vol.23
, pp. 160-170
-
-
Portenoy, R.K.1
-
43
-
-
0024818202
-
Non-cardiogenic pulmonary edema after narcotic treatment for cancer pain
-
43. Bruera E, Miller MJ. Non-cardiogenic pulmonary edema after narcotic treatment for cancer pain. Pain 1989; 39: 297-300.
-
(1989)
Pain
, vol.39
, pp. 297-300
-
-
Bruera, E.1
Miller, M.J.2
-
44
-
-
0027930510
-
Comparing the subjective, psychomotor and physiological effects of intravenous butorphanol and morphine in healthy volunteers
-
44. Zacny JP, Lichtor JL, Thapar P, Coalson D, Flemming D, Thompson WK. Comparing the subjective, psychomotor and physiological effects of intravenous butorphanol and morphine in healthy volunteers. J Pharmacol Exp Ther 1994; 270: 579-89.
-
(1994)
J Pharmacol Exp Ther
, vol.270
, pp. 579-589
-
-
Zacny, J.P.1
Lichtor, J.L.2
Thapar, P.3
Coalson, D.4
Flemming, D.5
Thompson, W.K.6
-
45
-
-
0026751191
-
Update on delirium
-
45. Lipowski ZJ. Update on delirium. Psychiatr Clin N Am 1992; 15: 335-46.
-
(1992)
Psychiatr Clin N Am
, vol.15
, pp. 335-346
-
-
Lipowski, Z.J.1
-
46
-
-
0026624722
-
Cognitive failure (CF) in patients with terminal cancer: A prospective study
-
46. Bruera E, Miller L, McCallion J, et al. Cognitive failure (CF) in patients with terminal cancer: a prospective study. J Pain Symp Manage 1992; 7: 192-5.
-
(1992)
J Pain Symp Manage
, vol.7
, pp. 192-195
-
-
Bruera, E.1
Miller, L.2
McCallion, J.3
-
47
-
-
0023266542
-
Antidepressants increase bioavailability of morphine in cancer patients
-
47. Ventafridda V, Ripamonti C, De Conno F, et al. Antidepressants increase bioavailability of morphine in cancer patients. Lancet 1987; 1: 1204.
-
(1987)
Lancet
, vol.1
, pp. 1204
-
-
Ventafridda, V.1
Ripamonti, C.2
De Conno, F.3
-
48
-
-
0025034181
-
Oral morphine in cancer pain: Influences on morphine and metabolite concentration
-
48. McQuay HJ, Carroll D, Faura CC, et al. Oral morphine in cancer pain: influences on morphine and metabolite concentration. Clin Pharmacol Ther 1990; 48: 236-44.
-
(1990)
Clin Pharmacol Ther
, vol.48
, pp. 236-244
-
-
McQuay, H.J.1
Carroll, D.2
Faura, C.C.3
-
49
-
-
0026518201
-
Organic hallucinosis in patients receiving high doses of opiates for cancer pain
-
49. Bruera E, Schoeller T, Montejo G. Organic hallucinosis in patients receiving high doses of opiates for cancer pain. Pain 1992; 48: 397-9.
-
(1992)
Pain
, vol.48
, pp. 397-399
-
-
Bruera, E.1
Schoeller, T.2
Montejo, G.3
-
50
-
-
0026519251
-
Clonazepam treatment of myoclonic contractions associated with high-dose opioids: Case report
-
50. Eisele JH, Grigsby EJ, Dea G. Clonazepam treatment of myoclonic contractions associated with high-dose opioids: case report. Pain 1992; 49: 231-2.
-
(1992)
Pain
, vol.49
, pp. 231-232
-
-
Eisele, J.H.1
Grigsby, E.J.2
Dea, G.3
-
51
-
-
0027508664
-
Putative role of hydromorphone metabolites in myoclonus
-
51. Babul N, Darke AC. Putative role of hydromorphone metabolites in myoclonus. Pain 1993; 52: 123.
-
(1993)
Pain
, vol.52
, pp. 123
-
-
Babul, N.1
Darke, A.C.2
-
52
-
-
0027311289
-
Opioid hyperexcitability: The application of alternate opioid therapy
-
52. MacDonald N, Der L, Allan S, et al. Opioid hyperexcitability: the application of alternate opioid therapy. Pain 1993; 53: 353-5.
-
(1993)
Pain
, vol.53
, pp. 353-355
-
-
MacDonald, N.1
Der, L.2
Allan, S.3
-
53
-
-
0017653599
-
Accumulation of normeperidine, an active metabolite of meperidine, in patients with renal failure or cancer
-
53. Szeto HH, Inturrisi CE, Houde R, et al. Accumulation of normeperidine, an active metabolite of meperidine, in patients with renal failure or cancer. Ann Intern Med 1977; 86: 738-41.
-
(1977)
Ann Intern Med
, vol.86
, pp. 738-741
-
-
Szeto, H.H.1
Inturrisi, C.E.2
Houde, R.3
-
54
-
-
0020675827
-
Central nervous system excitatory effects of meperidine in cancer patients
-
54. Kaiko RF, Foley KM, Grabinski PY, et al. Central nervous system excitatory effects of meperidine in cancer patients. Ann Neurol 1983; 13: 180-5.
-
(1983)
Ann Neurol
, vol.13
, pp. 180-185
-
-
Kaiko, R.F.1
Foley, K.M.2
Grabinski, P.Y.3
-
55
-
-
0023549913
-
Myoclonus following sufentanil without EEG seizure activity
-
55. Bowdle TA. Myoclonus following sufentanil without EEG seizure activity. Anesthesiology 1987; 67: 593-5.
-
(1987)
Anesthesiology
, vol.67
, pp. 593-595
-
-
Bowdle, T.A.1
-
57
-
-
0027527448
-
Hyperalgesia and myoclonus in terminal cancer patients treated with continuous intravenous morphine
-
57. Sjogren P, Jonsson T, Jensen N-H, et al. Hyperalgesia and myoclonus in terminal cancer patients treated with continuous intravenous morphine. Pain 1993; 55: 93-7.
-
(1993)
Pain
, vol.55
, pp. 93-97
-
-
Sjogren, P.1
Jonsson, T.2
Jensen, N.-H.3
-
58
-
-
0027944339
-
Disappearance of morphine-induced hyperalgesia after discontinuing or substituting morphine with other opioid agonists
-
58. Sjogren P, Jensen N-H, Jensen T-S. Disappearance of morphine-induced hyperalgesia after discontinuing or substituting morphine with other opioid agonists. Pain 1994; 59: 313-6.
-
(1994)
Pain
, vol.59
, pp. 313-316
-
-
Sjogren, P.1
Jensen, N.-H.2
Jensen, T.-S.3
-
60
-
-
0019524261
-
Intrathecal high dose morphine produces hyperalgesia in the rat
-
60. Woolf CJ. Intrathecal high dose morphine produces hyperalgesia in the rat. Brain Res 1981; 209: 491-5.
-
(1981)
Brain Res
, vol.209
, pp. 491-495
-
-
Woolf, C.J.1
-
61
-
-
0022558928
-
High dose of spinal morphine produces a nonopiate receptor-mediated hyperesthesia: Clinical and theoretic implications
-
61. Yaksh TL, Harty GJ, Onofrio BM. High dose of spinal morphine produces a nonopiate receptor-mediated hyperesthesia: clinical and theoretic implications. Anesthesiology 1986; 64: 590-7.
-
(1986)
Anesthesiology
, vol.64
, pp. 590-597
-
-
Yaksh, T.L.1
Harty, G.J.2
Onofrio, B.M.3
-
62
-
-
0026501373
-
Morphine-3-glucuronide may functionally antagonize morphine-6-glucuronide induced antinociception and ventilatory depression in the rat
-
62. Gong QL, Hedner J, Björkman R, Hedner T. Morphine-3-glucuronide may functionally antagonize morphine-6-glucuronide induced antinociception and ventilatory depression in the rat. Pain 1992; 48: 249-55.
-
(1992)
Pain
, vol.48
, pp. 249-255
-
-
Gong, Q.L.1
Hedner, J.2
Björkman, R.3
Hedner, T.4
-
63
-
-
0029162234
-
Mechanisms of hyperalgesia and morphine tolerance: A current view of their possible interactions
-
63. Mao J, Price DD, Mayer DJ. Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions. Pain 1995; 62: 259-74.
-
(1995)
Pain
, vol.62
, pp. 259-274
-
-
Mao, J.1
Price, D.D.2
Mayer, D.J.3
-
64
-
-
0021965084
-
Intrathecal morphine induces myoclonic seizures in the rat
-
64. Shohami E, Evron S. Intrathecal morphine induces myoclonic seizures in the rat. Acta Pharmacol Toxicol 1985; 56: 50-4.
-
(1985)
Acta Pharmacol Toxicol
, vol.56
, pp. 50-54
-
-
Shohami, E.1
Evron, S.2
-
65
-
-
0027275184
-
Spatial patterns of increased spinal cord membrane-bound protein kinase C and their relation to increases in C-2-deoxyglucose metabolic activity in rats with painful peripheral mononeuropathy
-
65. Mao J, Mayer DJ, Hayes RL, Price DD. Spatial patterns of increased spinal cord membrane-bound protein kinase C and their relation to increases in C-2-deoxyglucose metabolic activity in rats with painful peripheral mononeuropathy. J Neurophysiol 1993; 70: 470-81.
-
(1993)
J Neurophysiol
, vol.70
, pp. 470-481
-
-
Mao, J.1
Mayer, D.J.2
Hayes, R.L.3
Price, D.D.4
-
66
-
-
0028905662
-
Ketobemidone, methadone and pethidine are non-competitive N-methyl-D-asparate (NMDA) antagonists in the rat cortex and spinal cord
-
66. Ebert B, Andersen S, Krogsgaard-Larsen P. Ketobemidone, methadone and pethidine are non-competitive N-methyl-D-asparate (NMDA) antagonists in the rat cortex and spinal cord. Neurosci Lett 1995; 187: 165-8.
-
(1995)
Neurosci Lett
, vol.187
, pp. 165-168
-
-
Ebert, B.1
Andersen, S.2
Krogsgaard-Larsen, P.3
-
67
-
-
0029758390
-
Opioid rotation in patients with cancer pain. A retrospective comparison of dose ratios between methadone, hydromorphone and morphine
-
67. Bruera E, Pereira J, Watanabe S, Belzile M, Kuehn N, Hanson J. Opioid rotation in patients with cancer pain. A retrospective comparison of dose ratios between methadone, hydromorphone and morphine. Cancer 1996; 78: 852-7.
-
(1996)
Cancer
, vol.78
, pp. 852-857
-
-
Bruera, E.1
Pereira, J.2
Watanabe, S.3
Belzile, M.4
Kuehn, N.5
Hanson, J.6
-
68
-
-
0021816535
-
Continuons infusion of spinally administered narcotics for the relief of pain due to malignant disorders
-
68. Krames ES, Gershow Y, Glassberg A. Continuons infusion of spinally administered narcotics for the relief of pain due to malignant disorders. Cancer 1985; 56: 696-702.
-
(1985)
Cancer
, vol.56
, pp. 696-702
-
-
Krames, E.S.1
Gershow, Y.2
Glassberg, A.3
-
69
-
-
0028567815
-
Organic brain syndromes and opioid administration for cancer pain
-
69. Caraceni A, Martini C, De Conno F, et al. Organic brain syndromes and opioid administration for cancer pain. J Pain Symp Manage 1994; 9: 527-33.
-
(1994)
J Pain Symp Manage
, vol.9
, pp. 527-533
-
-
Caraceni, A.1
Martini, C.2
De Conno, F.3
-
70
-
-
0026750389
-
Circadian distribution of extra doses of narcotic analgesics in patients with cancer pain. A preliminary report
-
70. Bruera E, Macmillan K, Kuehn N, Miller MJ. Circadian distribution of extra doses of narcotic analgesics in patients with cancer pain. A preliminary report. Pain 1992; 49: 311-4.
-
(1992)
Pain
, vol.49
, pp. 311-314
-
-
Bruera, E.1
Macmillan, K.2
Kuehn, N.3
Miller, M.J.4
-
71
-
-
0029071983
-
Clinical efficacy and safety of a novel controlled release morphine suppository and subcutaneous morphine in cancer pain: A randomized evaluation
-
71. Bruera E, Fainsinger R, Spachynski K, Babul N, Harsanyi Z, Darke AC. Clinical efficacy and safety of a novel controlled release morphine suppository and subcutaneous morphine in cancer pain: a randomized evaluation. J Clin Oncol 1995; 13: 1520-7.
-
(1995)
J Clin Oncol
, vol.13
, pp. 1520-1527
-
-
Bruera, E.1
Fainsinger, R.2
Spachynski, K.3
Babul, N.4
Harsanyi, Z.5
Darke, A.C.6
-
72
-
-
0028021318
-
The use of hypodermoclysis for rehydration in terminally ill cancer patients
-
72. Fainsinger RL, MacEachern T, Miller MJ, et al. The use of hypodermoclysis for rehydration in terminally ill cancer patients. J Pain Symp Manage 1994; 9: 298-302.
-
(1994)
J Pain Symp Manage
, vol.9
, pp. 298-302
-
-
Fainsinger, R.L.1
MacEachern, T.2
Miller, M.J.3
-
73
-
-
0027935835
-
Psychostimulants as adjuvant analgesics
-
73. Bruera E, Watanabe S. Psychostimulants as adjuvant analgesics. J Pain Symp Manage 1994; 9: 412-5.
-
(1994)
J Pain Symp Manage
, vol.9
, pp. 412-415
-
-
Bruera, E.1
Watanabe, S.2
|